UK’s MHRA grants pharma WDA(H) license to JAS

JAS UK announced that it has been granted its Wholesale Distribution Authorisation (WDA(H)) license from the UK's Medicine and Healthcare Products Regulatory Agency (MHRA) for its Pharma and Healthcare Division.

The release reads, “In addition to the GDP-certified network JAS has developed, this achievement marks a significant milestone for JAS as it reinforces its commitment to providing innovative solutions for the international delivery of pharmaceutical products. With more operations spanning over 100 countries and a team of more than 7,000 professionals, JAS is known for its comprehensive logistics solutions and dedication to customer satisfaction.”

Adrian Frodsham, regional director for JAS, said: "We are pleased to have been granted our WDA(H) license after a stringent audit process. JAS UK's Pharma and Healthcare division prides itself of offering innovative solutions for the international delivery of pharmaceutical products, further enhancing the growth of our pre-established healthcare division."

While boasting an established healthcare division across its global network, the acquisition of the WDA(H) license empowers the UK division to seamlessly connect with its more than 40 GDP (Good Distribution Practice) certified overseas stations, enhancing its capabilities for handling pharmaceutical shipments.

Committed to adhering to the highest standards of quality and compliance, JAS UK has developed a purpose-built healthcare and pharmaceutical Electronic Quality Management System (QMS). This system, coupled with the WDA(H) license, further solidifies JAS's position as a trusted operator within the logistics industry.

In line with its expansion efforts, JAS UK's Pharma and Healthcare Division recently inaugurated a temperature-controlled storage facility in London. Spread across 5000 square feet, this facility features two CRT rooms designed to accommodate products requiring temperatures of 15°C to 25°C. Strategically located near London Heathrow Airport, the facility ensures the integrity of pharmaceutical products throughout the supply chain, providing customers with a safe, secure, and efficient door-to-door service.

It adds, “JAS UK remains committed to delivering exceptional services to its Pharma and healthcare customers, leveraging its expertise, infrastructure, and technological capabilities to meet evolving industry demands.”